 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | JK500 cell injection / Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Sciences
Enrollment open: Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia (clinicaltrials.gov) - Nov 28, 2022
P1, N=12, Recruiting, Sponsor: Institute of Hematology & Blood Diseases Hospital
Not yet recruiting --> Recruiting
- | JK500 cell injection / Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Sciences
New P1 trial: Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia (clinicaltrials.gov) - Aug 29, 2022
P1, N=12, Not yet recruiting, Sponsor: Institute of Hematology & Blood Diseases Hospital